PERRIGO Co plc (PRGO)
PERRIGO Co plc (PRGO) from its SEC filings: 2025 revenue $4.3 billion (-3% vs the year before), net margin -34%, free cash flow $145.1 million. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Pharmaceutical Preparations |
| Revenue (2025) | $4.3 billion |
| Revenue growth | -3% |
| Net income | -$1.4 billion |
| Net margin | -33.5% |
| Free cash flow | $145.1 million |
| Diluted EPS | $-10.29 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | -3% |
| Cash | $432.1 million |
| Long-term debt | $3.3 billion |
| Share count, 1 year | +1% |
| Fundamentals check | Weak fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.